Citation Impact
Citing Papers
Preferential Generation of Follicular B Helper T Cells from Foxp3 + T Cells in Gut Peyer's Patches
2009 StandoutScienceNobel
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
2011
Cutting Edge: TCR Stimulation Is Sufficient for Induction of Foxp3 Expression in the Absence of DNA Methyltransferase 1
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
2018
ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses
2006
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Concomitant regulation of T-cell activation and homeostasis
2004
Inflammation and metabolic disorders
2006 StandoutNature
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses
2019
Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases
2013
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
1996
Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency
2012
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone–cartilage interface and subchondral bone marrow
2006
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3+ precursors and impaired activated population
2010
Regulatory T Cells in Cancer
2010
Development of Foxp3+ Regulatory T Cells Is Driven by the c-Rel Enhanceosome
2009
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: Clinical and magnetic resonance imaging data
2005
Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
2008
Augmented photoswitching modulates immune signaling
2009
Differentiation and function of Foxp3+ effector regulatory T cells
2012
Regulatory T cells in autoimmune disease
2018
Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
2008
Role of the Microbiota in Immunity and Inflammation
2014 Standout
A human memory T cell subset with stem cell–like properties
2011
FOXP3 and scurfy: how it all began
2014 StandoutNobel
ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling
2009
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Basic principles of tumor-associated regulatory T cell biology
2012
Stat6-Independent GATA-3 Autoactivation Directs IL-4-Independent Th2 Development and Commitment
2000
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Identification of preexisting adaptive immunity to Cas9 proteins in humans
2019
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
2005
Ankylosing spondylitis
2007 Standout
Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells
2010
The Regulation of Immunity to Leishmania Major
1995 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Extrafollicular antibody responses
2003
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
2018
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
2011
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Dendritic cell regulation of TH1-TH2 development
2000
Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity
2012
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis
2003
DNA methylation controls Foxp3 gene expression
2008
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
Crosstalk in NF-κB signaling pathways
2011 Standout
Cytokine gene polymorphisms relevant for the spondyloarthropathies
2001
Instruction of Distinct CD4 T Helper Cell Fates by Different Notch Ligands on Antigen-Presenting Cells
2004 StandoutNobel
Positive and negative influences of regulatory T cells on tumour immunity
2008
Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells
2012
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
2004
Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection
2016
Endoplasmic Reticulum Stress Signaling in Disease
2006
Good cop, bad cop: the different faces of NF-κB
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression
2016
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
HIV Infection Rapidly Induces and Maintains a Substantial Suppression of Thymocyte Proliferation
2004
Integrating cell-signalling pathways with NF-κB and IKK function
2006 Standout
Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype
2007
Regulatory T Cells: Mechanisms of Differentiation and Function
2007 Standout
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Single Cell Analysis Reveals That IL-4 Receptor/Stat6 Signaling Is Not Required for the In Vivo or In Vitro Development of CD4+ Lymphocytes with a Th2 Cytokine Profile
2000
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Heterogeneity of natural Foxp3 + T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity
2009
From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
2016
Immuno-Navigator, a batch-corrected coexpression database, reveals cell type-specific gene networks in the immune system
2016 StandoutNobel
The Percentage of FoxP3+Helios+ Treg Cells Correlates Positively With Disease Activity in Systemic Lupus Erythematosus
2013
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs
2004
Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis
2007
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
2015
CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines
2013
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
2003
Human Memory Helios− FOXP3+ Regulatory T Cells (Tregs) Encompass Induced Tregs That Express Aiolos and Respond to IL-1β by Downregulating Their Suppressor Functions
2013
Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans
2013
Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection
2015
Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling
2007 StandoutNobel
Conditional stability of T cells
2010 StandoutNatureNobel
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation
2020 StandoutNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Human blood T fr cells are indicators of ongoing humoral activity not fully licensed with suppressive function
2017
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
2015
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
2014
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response
2008
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of Andreas Thiel being referenced
A Converse 4-1BB and CD40 Ligand Expression Pattern Delineates Activated Regulatory T Cells (Treg) and Conventional T Cells Enabling Direct Isolation of Alloantigen-Reactive Natural Foxp3+ Treg
2012
Antigen-specific cytometry.
1999
TCR Repertoire Analysis by Next Generation Sequencing Allows Complex Differential Diagnosis of T Cell–Related Pathology
2013
Long-lived Plasma Cells Survive Independent of Antigen
1999
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells
2007
Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi
2013
Plasma Cell-Like Morphology of Th1-Cytokine-Producing Cells Associated with the Loss of CD3 Expression
2004
Down‐regulation of the nonspecific and antigen‐specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab
2003
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus
2012
The small subset of CD56brightCD16– natural killer cells is selectively responsible for both cell proliferation and interferon‐γ production upon interaction with dendritic cells
2004
HLA–B27–restricted CD8+ T cell response to cartilage‐derived self peptides in ankylosing spondylitis
2005
Novel GMP-Compatible Protocol Employing an Allogeneic B Cell Bank for Clonal Expansion of Allospecific Natural Regulatory T Cells
2014
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression
2005
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells
2005
Low T cell production of TNFα and IFNγ in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism
2001
Impaired Peripheral Th1 CD4+ T Cell Response to Escherichia coli Proteins in Patients with Crohn’s Disease and Ankylosing Spondylitis
2011
Substitution in Position 3 of Cyclosporin A Abolishes the Cyclophilin-mediated Gain-of-function Mechanism but Not Immunosuppression
2004
Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry
2000
The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1
2004
Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells.
1994
Life after the thymus: CD31+ and CD31− human naive CD4+ T-cell subsets
2008
The early cellular signatures of protective immunity induced by live viral vaccination
2012
Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood
2002
Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases
2001
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses
2006